High Proportion of Anorectal Chlamydia trachomatis and Neisseria gonorrhoeae After Routine Universal Urogenital and Anorectal Screening in Women Visiting the Sexually Transmitted Infection Clinic
Author(s) -
Geneviève A. F. S. van Liere,
Nicole H. T. M. Dukers–Muijrers,
Luuk T.J. Levels,
Christian J. P. A. Hoebe
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix243
Subject(s) - gonorrhea , medicine , chlamydia , chlamydia trachomatis , neisseria gonorrhoeae , gynecology , odds ratio , lymphogranuloma venereum , sexually transmitted disease , men who have sex with men , obstetrics , confidence interval , syphilis , immunology , biology , human immunodeficiency virus (hiv) , microbiology and biotechnology
Testing on indication of self-reported anal sex or symptoms is used to manage anorectal Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infections in women. Little is known about the impact of another testing strategy, routine universal anorectal screening with respect to chlamydia and gonorrhea prevalence and risk factors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom